OVER EXPRESSION OF SMOOTH MUSCLE THIN FILAMENT ASSOCIATED PROTEINS IN THE BLADDER WALL OF DIABETICS
- 1 July 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 174 (1) , 360-364
- https://doi.org/10.1097/01.ju.0000161602.18671.c7
Abstract
The thin filament associated proteins caldesmon, tropomyosin and calponin have been shown to modulate actin-myosin interaction, actomyosin adenosine triphosphatase and contraction in smooth muscle. This study was performed to determine whether the expression of these proteins is altered in diabetes induced decrease in the contractility of bladder wall smooth muscle. Detrusor samples were obtained from New Zealand White male rabbits with alloxan induced diabetes, and from age and sex matched control rabbits. In addition, a bladder myocyte cell line, which continues to express smooth muscle phenotype, was exposed to either normal (5 mM) or high (50 mM) concentrations of glucose. The levels of expression of the thin filament associated proteins were determined at the mRNA and protein levels by reverse transcriptase-polymerase chain reaction and Western blotting, respectively. Detrusor smooth muscle tissue from rabbits with alloxan induced diabetes showed over expression of thin filament associated proteins, calponin, tropomyosin and caldesmon when compared with that of the control. Similar up-regulation was seen also in bladder myocytes in cultures treated with 50 mM glucose, indicating that the high glucose induced the changes. Our results suggest that the increased expression of thin filament proteins, calponin, tropomyosin and caldesmon in diabetic rabbits might alter the contractile and cytoskeletal structure in bladder myocytes. The over expression of these thin filament associated proteins, which suppresses actin-myosin interaction and actomyosin adenosine triphosphatase, and the enhancement of this suppression by tropomyosin are likely to have an effect on the relationship between force and myosin light chain phosphorylation, requiring higher levels of phosphorylation in diabetic detrusor compared with that of control. The downstream effects of high glucose (eg oxidative stress) appear to modulate the transcriptional regulation of thin filament mediated regulatory proteins in bladder smooth muscle.Keywords
This publication has 19 references indexed in Scilit:
- DIABETES INDUCED DECREASE IN DETRUSOR SMOOTH MUSCLE FORCE IS ASSOCIATED WITH OXIDATIVE STRESS AND OVERACTIVITY OF ALDOSE REDUCTASEJournal of Urology, 2005
- Diabetes decreases rabbit bladder smooth muscle contraction while increasing levels of myosin light chain phosphorylationAmerican Journal of Physiology-Renal Physiology, 2004
- Role of Protein Phosphatase Type 1 in Contractile Functions: Myosin PhosphataseJournal of Biological Chemistry, 2004
- Oxidant driven signaling pathways during diabetes: role of Rac1 and modulation of protein kinase activity in mouse urinary bladderBiochimie, 2004
- Smooth Muscle Hypertrophy Following Partial Bladder Outlet Obstruction Is Associated with Overexpression of Non-Muscle CaldesmonThe American Journal of Pathology, 2004
- Caldesmon: binding to actin and myosin and effects on elementary steps in the ATPase cycleActa Physiologica Scandinavica, 1998
- Regulation of actomyosin and contraction in smooth muscleWorld Journal of Urology, 1994
- Caldesmon inhibits the cooperative turning-on of the smooth muscle heavy meromyosin by tropomyosin-actinBiochemistry, 1989
- Rat bladder in the early stages of streptozotocin-induced diabetes: adrenergic and cholinergic innervationDiabetologia, 1984
- Bladder dysfunction and neuropathy in diabetesDiabetologia, 1976